Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Adjuvant Radiotherapy. Found 45 abstracts

no pagination
Churilla TM, Ballman KV, Brown PD, Twohy EL, Jaeckle K, Farace E, Cerhan JH, Anderson SK, Carrero XW, Garces YI, Barker FG, Deming R, Dixon JG, Burri SH, Chung C, Menard C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial. Int J Radiat Oncol Biol Phys. 2017 Aug 05;99(5):1173-8.   PMCID: PMC5699951
Gore JL, du Plessis M, Santiago-Jimenez M, Yousefi K, Thompson DJ, Karsh L, Lane BR, Franks M, Chen DY, Bandyk M, Bianco FJ, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW. Decipher Test Impacts Decision Making Among Patients Considering Adjuvant and Salvage Treatment After Radical Prostatectomy: Interim Results From the Multicenter Prospective PRO-IMPACT Study. Cancer. 2017 Aug;123(15):2850-9.   PMCID: PMC5573983
Wang LS, Handorf EA, Wu H, Liu JC, Perlis CS, Galloway TJ. Surgery and Adjuvant Radiation for High-risk Skin Adnexal Carcinoma of the Head and Neck. Am J Clin Oncol. 2017 Aug;40(4):429-32.   PMCID: PMC4504824
Xu MJ, Chu C, Rubin S, Lin LL. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma. Am J Clin Oncol. 2017 Dec;40(6):598-604.   PMCID: PMC4733581
Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz M, Goldstein LJ, Hudis CA, Isakoff SJ, Kelly Marcom P, Mayer IA, McCormick B, Moran M, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. Invasive breast cancer version 1.2016. JNCCN Journal of the National Comprehensive Cancer Network. 2016 Mar;14(3):324-54.
Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016 Jan;26(1):141-8.
Porpiglia AS, Sigurdson ER. Surgical Options in the Treatment of Lower Gastrointestinal Tract Cancers. Current treatment options in oncology. 2015 Sep;16(9):46.
Powers BD, Montes JA, Nguyen DC, Nick DA, Daly MP, Davey A, Willis AI. Demographic risk factors impacting timely radiation therapy completion after breast conserving surgery. Am J Surg. 2015 Nov;210(5):891-5.
Zhang I, Zaorsky NG, Palmer JD, Mehra R, Lu B. Targeting brain metastases in ALK-rearranged non-small-cell lung cancer. Lancet Oncol. 2015 Oct;16(13):e510-21.
Kalbasi A, Swisher-McClure S, Mitra N, Sunderland R, Smaldone MC, Uzzo RG, Bekelman JE. Low Rates of Adjuvant Radiation in Patients With Nonmetastatic Prostate Cancer With High-Risk Pathologic Features. Cancer. 2014 Oct;120(19):3089-96.   PMCID: 4277873
Li L, Quang TS, Gracely EJ, Kim JH, Emrich JG, Yaeger TE, Jenrette JM, Cohen SC, Black P, Brady LW. A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. J Neurosurg. 2010 Aug;113(2):192-8.   PMCID: not NIH funded
Abramowitz MC, Pollack A. Postprostatectomy radiation therapy for prostate cancer. Semin Radiat Oncol. 2008 Jan;18(1):15-22.
Small W, Berlin J, Freedman GM, Lawrence T, Talamonti MS, Mulcahy MF, Chakravarthy AB, Konski AA, Zalupski MM, Philip PA, Kinsella TJ, Merchant NB, Hoffman JP, Benson AB, Nicol S, Xu RM, Gill JF, McGinn CJ. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol. 2008 Feb 20;26(6):942-7.
Stitzenberg KB, Watson JC, Roberts A, Kagan SA, Cohen SJ, Konski AA, Hoffman JP. Survival after pancreatectomy with major arterial resection and reconstruction. Ann Surg Oncol. 2008 May;15(5):1399-406.
Kunkle DA, Haas NB, Uzzo RG. Adjuvant therapy for high-risk renal cell carcinoma patients. Current urology reports. 2007 Jan;8(1):19-30.
O'Sullivan MJ, Morrow M. Ductal carcinoma in situ--current management. Surgical Clinics of North America. 2007 Apr;87(2):333-51.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Rectal cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):492-508.
Langer CJ. Irinotecan in advanced lung cancer: focus on North American trials. Oncology (Huntington). 2004 Jun;18(7 Suppl 4):17-28.
Brown TA, Ridge JA, Goldberg M. Gastrostomy-site tumor recurrence is not always fatal. Surgical endoscopy. 2003 Feb;17(2):351.
Kaminski JM, Hanlon AL, Joon DL, Meistrich M, Hachem P, Pollack A. Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth. Int J Radiat Oncol Biol Phys. 2003 Sep;57(1):24-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Adjuvant Radiotherapy

Adjuvant Radiotherapy pathology Female therapy Male Aged Neoplasm Staging Middle Aged Adjuvant Chemotherapy Combined Modality Therapy therapeutic use mortality methods Local Neoplasm Recurrence surgery Antineoplastic Combined Chemotherapy Protocols radiotherapy 80 and over Aged Survival Rate Prostatic Neoplasms administration & dosage Prognosis Adult Lung Neoplasms secondary Risk Assessment Retrospective Studies Non-Small-Cell Lung Carcinoma Prostatectomy tu [Therapeutic Use] Logistic Models United States adverse effects Breast Neoplasms Brachytherapy Multivariate Analysis Brain Neoplasms Randomized Controlled Trials Neoplasm Invasiveness drug therapy Deoxycytidine Use] Lymph Node Excision Neoplasm Grading dt [Drug Therapy] Comparative Study tu [Therapeutic Carcinosarcoma Cohort Studies Antineoplastic Agents derivatives Segmental Mastectomy Mastectomy Age Factors Survival Analysis su [Surgery] Camptothecin prostate cancer aa [Analogs & Derivatives] Salvage Therapy Pancreatic Neoplasms Follow-Up Studies Prospective Studies Treatment Outcome drug effects Rectal Neoplasms Adenocarcinoma Hysterectomy Antineoplastic Antimetabolites Human Fluorouracil 7689-03-4 (Camptothecin) immunology 0 (Antineoplastic Combined Chemotherapy Protocols) Squamous Cell Carcinoma Risk Factors EC 1-17-4 (Ribonucleotide Reductases) Head and Neck Neoplasms Organoplatinum Compounds Genetic Predisposition to Disease Monoclonal Antibodies psychology Breast conserving treatment Gastrointestinal Endoscopy 103882-84-4 (gemcitabine) Neoadjuvant Therapy Renal Cell Carcinoma 100286-90-6 (irinotecan) analogs & Radiosurgery st [Standards] Androgen Antagonists Mouth Neoplasms African Continental Ancestry Group Tamoxifen Tumor Microenvironment Pancreaticoduodenectomy Phenotype Capillary Permeability Phytogenic) 0 (Antineoplastic Agents Receptor Protein-Tyrosine Kinases Glioblastoma Ductal Carcinoma-Breast Alkylating Antineoplastic Agents Conformal Radiotherapy antagonists & inhibitors Decipher metabolism Anus Neoplasms Clear Cell Adenocarcinoma 0 (Organoplatinum Compounds) Orchiectomy Small Cell Carcinoma 0 (Taxoids) 0 (Folfox protocol) decisional conflict Colostomy Conflict (Psychology) Surveys and Questionnaires Radioimmunotherapy Endometrial Neoplasms drug administration & epidemiology Endometrioid Carcinoma Chemoradiotherapy Kaplan-Meiers Estimate 10540-29-1 (Tamoxifen) 33419-42-0 (Etoposide) Middle Age Vomiting CA-19-9 Antigen Case Report Rats blood Hormonal) 0 (Antineoplastic Agents 15663-27-1 (Cisplatin) Type I DNA Topoisomerases Cisplatin Gene Rearrangement Abdominal Neoplasms Remission Induction Medicaid Leucovorin Evidence-Based Medicine Etoposide Residence Characteristics Carcinoma in Situ 0 (Antineoplastic Agents) Early Detection of Cancer
Last updated on Friday, August 07, 2020